financetom
Business
financetom
/
Business
/
Philips to Offer Mobile Cardiac Telemetry on Optum Healthcare's Network in US
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Philips to Offer Mobile Cardiac Telemetry on Optum Healthcare's Network in US
Sep 25, 2025 7:22 AM

09:50 AM EDT, 09/25/2025 (MT Newswires) -- Royal Philips (PHG) said Thursday it formed a partnership with Optum Healthcare in the US, under which Philips' Mobile Cardiac Telemetry and Extended Holter services will be included in the latter's network for enhanced cardiac monitoring.

Financial terms were not disclosed.

The company's services are now available to Optum's 3.4 million members in 22 US states, Philips said, adding that the collaboration will expand its offering throughout commercial, Medicare, Medicare Advantage or Managed Medicare, and Medicaid plans.

Philips' stock was down 2.6% in recent Thursday trading.

Price: 26.67, Change: -0.71, Percent Change: -2.61

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla's Musk to unveil robotaxis amid fanfare and skepticism
Tesla's Musk to unveil robotaxis amid fanfare and skepticism
Oct 10, 2024
* Musk expected to showcase robotaxi prototype, ride-hailing app * Investors seek robotaxi production timeline, business plan * Progress on humanoid robots, cheaper versions of its EVs awaited By Abhirup Roy and Akash Sriram Oct 10 (Reuters) - Tesla is set to unveil its long-promised robotaxi in Hollywood late on Thursday and update investors on artificial intelligence projects, efforts CEO...
Upstream Bio raises $255 mln in US IPO
Upstream Bio raises $255 mln in US IPO
Oct 10, 2024
Oct 10 (Reuters) - Upstream Bio, which is developing treatments for some respiratory disorders, said on Thursday it had raised $255 million in its initial public offering in the United States. The drug developer joins a swath of biotech companies rushing towards a stock market listing as a long-awaited policy easing cycle begins. September was the busiest month for healthcare...
J&J talc bankruptcy stays in Texas despite 'forum-shopping' opposition
J&J talc bankruptcy stays in Texas despite 'forum-shopping' opposition
Oct 10, 2024
NEW YORK (Reuters) -A Johnson & Johnson subsidiary can pursue its third attempt to resolve tens of thousands of lawsuits alleging its talc products caused cancer in a Texas bankruptcy court, a judge ruled on Thursday, allowing the company to avoid a venue that shot down its two previous efforts. U.S. Bankruptcy Judge Christopher Lopez at a hearing in Houston...
Kaiser Permanente-backed biopharma CAMP4 raises $75 mln in US IPO
Kaiser Permanente-backed biopharma CAMP4 raises $75 mln in US IPO
Oct 10, 2024
Oct 10 (Reuters) - CAMP4 Therapeutics, a biopharmaceutical firm backed by healthcare giant Kaiser Permanente on Thursday raised $75 million after pricing its U.S. initial public offering (IPO). CAMP4 sold 6.82 million shares in the IPO for $11 per share, the company said in a statement. (Reporting by Pretish M J in Bengaluru) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved